Clinical trial

Zinc Supplements in Lowering Cadmium Levels in Smokers

NCT00376987 · Wake Forest University Health Sciences, Other · Completed

Key facts

NCT number NCT00376987
Title Zinc Supplements in Lowering Cadmium Levels in Smokers
Official title Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Lead sponsor Wake Forest University Health Sciences, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer and 1 more
Intervention type Dietary Supplement
Interventions zinc oxide
Enrollment 61
Start date Dec 1, 2003
Primary completion Oct 1, 2006
Completion Jun 1, 2015
First posted Sep 15, 2006
Last update posted May 30, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies